References
- Feldman RL, Sullivan EK, Ratliff M, et al. Comparison of travoprost 0.0015% and 0.004% with timolol in patients with elevated intraocular pressure. Ophthalmology 2001;109:998–1008
- Goldberg I, CunhaVaz J, Jakobsen JE, et al. Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with openangle glaucoma and ocular hypertension. J Glaucoma 2001;10:414–22
- Netland PA, Landry T, Sullivan EK, et al. Travoprost compared with latanoprost and timolol in patients with openangle glaucoma or ocular hypertension. Am J Ophthalmol 2001;132:472–84
- OrengoNania S, Landry T, Von Tress M, et al. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%. Am J Ophthalmol 2001;132:860–8
- Parrish RK, Palmberg P, Sheu WP; for the XLT Study Group. A comparison of latanoprost, bimatoprost and travoprost in patients with elevated intraocular pressure: a 12week, randomized, maskedevaluator multicenter study. Am J Ophthalmol 2003;135: 688–703
- Kaback M, Geanon J, Katz G, et al. Ocular hypotensive efficacy of travoprost in patients unsuccessfully treated with latanoprost. Curr Med Res Opin 2004;20:1341–5
- Przydryga JT, Engloff C and the Swiss START Study Group. Intraocular pressure lowering efficacy of travoprost. Eur J Ophthalmol 2004;14:416–22
- MartinezdelaCasa JM, Castillo A, GarciaFeijoo J, et al. Concomitant administration of travoprost and brinzolamide versus fixed latanoprost/timolol combined therapy: threemonth comparison of the efficacy and safety. Curr Med Res Opin 2004;20:1333–9
- Dubiner HB, Sircy MD, Landry T, et al. Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44hour period in patients with elevated intraocular pressure. Clin Ther 2004;26:84–91
- Hellberg MR, SAllee VL, McLaughlin MA, et al. Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist. J Ocular Pharmacol Ther 2001;17:421–32
- Olthoff CMG, Schouten JSAG, de Borne BW, Webers CAB. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension. Ophthalmology 2005;112:953–61
- Steinert RF, Thomas JV, Boger WP. Longterm drift and continued efficacy after multiyear timolol therapy. Arch Ophthalmol 1981;99:100–3